Quick Access Reports

Canada Clinical Diagnostics Market Analysis

Canada's clinical diagnostics is expected to witness significant growth from $3.9 Bn in 2022 to $4.9 Bn in 2030 with a CAGR of 3.1% for the year 2022-30. The main growth drivers of the Canadian clinical diagnostics market are growing awareness about early disease detection and the benefits of early treatment. Further, the increasing investments by the government in diagnostic services are responsible for the market growth. The market is segmented by molecular diagnostics and end users. LifeLabs, SickKids, and Dynacare are some of the top players in this market.